These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29127443)

  • 1. Astragaloside IV attenuates orbital inflammation in Graves' orbitopathy through suppression of autophagy.
    Li H; Zhang Y; Min J; Gao L; Zhang R; Yang Y
    Inflamm Res; 2018 Feb; 67(2):117-127. PubMed ID: 29127443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
    Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
    Lee CE; Choi SH; Yoon JS
    Korean J Ophthalmol; 2020 Jun; 34(3):192-202. PubMed ID: 32495527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neferine suppresses autophagy-induced inflammation, oxidative stress and adipocyte differentiation in Graves' orbitopathy.
    Li H; Gao L; Min J; Yang Y; Zhang R
    J Cell Mol Med; 2021 Feb; 25(4):1949-1957. PubMed ID: 33443817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy is involved in the initiation and progression of Graves' orbitopathy.
    Yoon JS; Lee HJ; Chae MK; Lee EJ
    Thyroid; 2015 Apr; 25(4):445-54. PubMed ID: 25687157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy.
    Yoon JS; Chae MK; Lee SY; Lee EJ
    Br J Ophthalmol; 2012 Aug; 96(8):1117-21. PubMed ID: 22661653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
    Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
    Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
    Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
    Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
    Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
    Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy.
    Yoon JS; Chae MK; Jang SY; Lee SY; Lee EJ
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5921-9. PubMed ID: 22871832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
    Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS
    Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy.
    Yoon JS; Lee HJ; Choi SH; Chang EJ; Lee SY; Lee EJ
    PLoS One; 2011; 6(10):e26261. PubMed ID: 22039452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    Choi YJ; Kim C; Choi EW; Lee SH; Chae MK; Jun HO; Kim BY; Yoon JS; Jang SY
    PLoS One; 2022; 17(8):e0270416. PubMed ID: 35980936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
    Ko J; Kim JY; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
    Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
    Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy.
    Kim BR; Kim J; Lee JE; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):39. PubMed ID: 32196098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
    Lee JS; Chae MK; Kikkawa DO; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):51. PubMed ID: 32735324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.